GB Sciences Management
Management criteria checks 4/4
GB Sciences' CEO is John Poss, appointed in Apr 2016, has a tenure of 8.08 years. total yearly compensation is $60.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.055% of the company’s shares, worth $1.46K. The average tenure of the management team and the board of directors is 8.1 years and 8.1 years respectively.
Key information
John Poss
Chief executive officer
US$60.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 8.1yrs |
| CEO ownership | 0.06% |
| Management average tenure | 8.1yrs |
| Board average tenure | 8.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | US$60k | US$60k | -US$4m |
| Dec 31 2022 | n/a | n/a | -US$5m |
| Sep 30 2022 | n/a | n/a | US$99k |
| Jun 30 2022 | n/a | n/a | -US$86k |
| Mar 31 2022 | US$103k | US$69k | -US$147k |
| Dec 31 2021 | n/a | n/a | US$3m |
| Sep 30 2021 | n/a | n/a | -US$2m |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | US$94k | US$75k | -US$3m |
| Dec 31 2020 | n/a | n/a | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$3m |
| Mar 31 2020 | US$158k | US$120k | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$5m |
| Sep 30 2019 | n/a | n/a | -US$11m |
| Jun 30 2019 | n/a | n/a | -US$18m |
| Mar 31 2019 | US$257k | US$120k | -US$21m |
| Dec 31 2018 | n/a | n/a | -US$26m |
| Sep 30 2018 | n/a | n/a | -US$30m |
| Jun 30 2018 | n/a | n/a | -US$25m |
| Mar 31 2018 | US$692k | US$120k | -US$23m |
Compensation vs Market: John's total compensation ($USD60.00K) is below average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
CEO
John Poss (75 yo)
8.1yrs
Tenure
US$60,000
Compensation
Mr. John Claybron Poss has been the Chief Executive Officer of GB Sciences, Inc. (formerly, Growblox Sciences, Inc.) since April 29, 2016, serves as its Chairman since May 8, 2017 and serves as its Interim...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Interim CFO & Chairman | 8.1yrs | US$60.00k | 0.055% $ 1.5k | |
| Chairman of Scientific Advisory Board | 9.9yrs | US$138.00k | 0.029% $ 752.9 | |
| Securities Counsel & Company Secretary | 2.9yrs | no data | 0% $ 0 |
8.1yrs
Average Tenure
69yo
Average Age
Experienced Management: GBLX's management team is seasoned and experienced (8.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Interim CFO & Chairman | 8.1yrs | US$60.00k | 0.055% $ 1.5k | |
| Chairman of Scientific Advisory Board | 9.9yrs | US$138.00k | 0.029% $ 752.9 | |
| Independent Director | 4.6yrs | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
8.1yrs
Average Tenure
55yo
Average Age
Experienced Board: GBLX's board of directors are considered experienced (8.1 years average tenure).